v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Redeemable Non-Controlling Interests
Beginning Balance at Dec. 31, 2022   $ 430          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment $ (155)       $ (155)    
Net income (loss)   (11)          
Ending Balance at Mar. 31, 2023   419          
Beginning balance (in shares) at Dec. 31, 2022     2,005,486        
Beginning balance at Dec. 31, 2022 8,074   $ 0 $ 40,550 (443) $ (32,767) $ 734
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     1,208        
Exercise of stock options 5     5      
Stock-based compensation 482     482      
Issuance of common stock for settlement of RSUs (in shares)     12,708        
Shares withheld related to net share settlement (in shares)     (208)        
Shares withheld related to net share settlement (7)     (7)      
Foreign currency translation adjustment (155)       (155)    
Net income (loss) (146)         (157) 11
Ending balance (in shares) at Mar. 31, 2023     2,019,194        
Ending balance at Mar. 31, 2023 8,253   $ 0 41,030 (598) (32,924) 745
Beginning Balance at Dec. 31, 2022   430          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment 2            
Ending Balance at Jun. 30, 2023   408          
Beginning balance (in shares) at Dec. 31, 2022     2,005,486        
Beginning balance at Dec. 31, 2022 8,074   $ 0 40,550 (443) (32,767) 734
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (2)            
Foreign currency translation adjustment 2            
Ending balance (in shares) at Jun. 30, 2023     2,038,892        
Ending balance at Jun. 30, 2023 9,420   $ 0 41,637 (443) (32,530) 756
Beginning Balance at Mar. 31, 2023   419          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment 157       157    
Net income (loss)   (11)          
Ending Balance at Jun. 30, 2023   408          
Beginning balance (in shares) at Mar. 31, 2023     2,019,194        
Beginning balance at Mar. 31, 2023 8,253   $ 0 41,030 (598) (32,924) 745
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     1,859        
Exercise of stock options 10     10      
Stock-based compensation 515     515      
Issuance of common stock for settlement of RSUs (in shares)     14,096        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)     4,078        
Issuance of common stock under the Employee Stock Purchase Plan 85     85      
Shares withheld related to net share settlement (in shares)     (76)        
Shares withheld related to net share settlement (3)     (3)      
Repurchase of common stock (in shares)     (259)        
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (2)       (2)    
Foreign currency translation adjustment 157       157    
Net income (loss) 405         394 11
Ending balance (in shares) at Jun. 30, 2023     2,038,892        
Ending balance at Jun. 30, 2023 9,420   $ 0 41,637 (443) (32,530) 756
Beginning Balance at Dec. 31, 2023   654          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment $ (8) (2)     (8)    
Recognition of non-controlling interest upon capital investment   19          
Net income (loss)   (20)          
Ending Balance at Mar. 31, 2024   651          
Beginning balance (in shares) at Dec. 31, 2023 2,071,144   2,071,144        
Beginning balance at Dec. 31, 2023 $ 12,028   $ 0 42,264 (421) (30,594) 779
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     2,421        
Exercise of stock options 18     18      
Stock-based compensation 493     493      
Issuance of common stock for settlement of RSUs (in shares)     13,160        
Shares withheld related to net share settlement (in shares)     (478)        
Shares withheld related to net share settlement (36)     (36)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (8)       (8)    
Foreign currency translation adjustment (8) (2)     (8)    
Net income (loss) (643)         (654) 11
Other 4     4      
Ending balance (in shares) at Mar. 31, 2024     2,086,247        
Ending balance at Mar. 31, 2024 11,848   $ 0 42,743 (437) (31,248) 790
Beginning Balance at Dec. 31, 2023   654          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment $ (49)            
Ending Balance at Jun. 30, 2024   631          
Beginning balance (in shares) at Dec. 31, 2023 2,071,144   2,071,144        
Beginning balance at Dec. 31, 2023 $ 12,028   $ 0 42,264 (421) (30,594) 779
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 5,206            
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax $ (9)            
Foreign currency translation adjustment $ (49)            
Ending balance (in shares) at Jun. 30, 2024 2,097,951   2,097,951        
Ending balance at Jun. 30, 2024 $ 13,152   $ 0 43,062 (479) (30,233) 802
Beginning Balance at Mar. 31, 2024   651          
Redeemable Non-Controlling Interests              
Foreign currency translation adjustment (41) (1)     (41)    
Net income (loss)   (19)          
Ending Balance at Jun. 30, 2024   631          
Beginning balance (in shares) at Mar. 31, 2024     2,086,247        
Beginning balance at Mar. 31, 2024 11,848   $ 0 42,743 (437) (31,248) 790
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     2,760        
Exercise of stock options 73     73      
Exercise of restricted stock units (in shares)     469        
Stock-based compensation 470     470      
Issuance of common stock for settlement of RSUs (in shares)     10,488        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)     2,893        
Issuance of common stock under the Employee Stock Purchase Plan 103     103      
Shares withheld related to net share settlement (in shares)     (68)        
Shares withheld related to net share settlement (5)     (5)      
Repurchase of common stock (in shares)     (4,838)        
Repurchase of common stock (326)     (326)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (1)       (1)    
Foreign currency translation adjustment (41) $ (1)     (41)    
Net income (loss) 1,027         1,015 12
Other $ 4     4      
Ending balance (in shares) at Jun. 30, 2024 2,097,951   2,097,951        
Ending balance at Jun. 30, 2024 $ 13,152   $ 0 $ 43,062 $ (479) $ (30,233) $ 802